Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate Roivant Sciences Ltd before investing.

In this article, we go over a few key elements for understanding Roivant Sciences Ltd’s stock price such as:

• Roivant Sciences Ltd’s current stock price and volume
• Why Roivant Sciences Ltd’s stock price changed recently
• Upgrades and downgrades for ROIV from analysts
• ROIV’s stock price momentum as measured by its relative strength

About Roivant Sciences Ltd (ROIV)

Before we jump into Roivant Sciences Ltd’s stock price, history, target price and what caused it to recently rise, let’s take a look at some background.

Roivant Sciences Ltd. is a commercial-stage biopharmaceutical company that seeks to improve the lives of patients by accelerating the development and commercialization of medicines that matter. The Company’s pipeline is focused on inflammation and immunology and includes VTAMA, a novel topical approved for the treatment of psoriasis and in development for the treatment of atopic dermatitis; batoclimab and IMVT-1402, fully human monoclonal antibodies targeting the neonatal Fc receptor (FcRn) in development across several IgG-mediated autoimmune indications; and RVT-3101, an anti-TL1A antibody in development for ulcerative colitis and Crohn’s disease, in addition to various other therapies in various stages of clinical development. The Company advances its pipeline by creating nimble subsidiaries or Vants to develop and commercialize its medicines and technologies. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business.

Want to learn more about Roivant Sciences Ltd’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about Roivant Sciences Ltd.

Roivant Sciences Ltd’s Stock Price as of Market Close

As of April 03, 2024, 4:00 PM, CST, Roivant Sciences Ltd’s stock price was $11.51.

Roivant Sciences Ltd is up 5.4% from its previous closing price of $10.92.

During the last market session, Roivant Sciences Ltd’s stock traded between $10.55 and $11.26. Currently, there are 800.59 million shares of Roivant Sciences Ltd stock available for purchase.

Roivant Sciences Ltd’s price-earnings (P/E) ratio is currently at 2.2, which is low compared to the Pharmaceuticals industry median of 24.3. The price-earnings ratio gauges market expectation of future performance by relating a stock’s current share price to its earnings per share.

Roivant Sciences Ltd Stock Price History

Roivant Sciences Ltd’s (ROIV) price is currently up 9.2% so far this month.

During the month of April, Roivant Sciences Ltd’s stock price has reached a high of $11.55 and a low of $10.15.

Over the last year, Roivant Sciences Ltd has hit prices as high as $13.24 and as low as $6.97. Year to date, Roivant Sciences Ltd’s stock is up 44.06%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused Roivant Sciences Ltd Stock’s Price to Rise?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of April 02, 2024, there was 1 analyst who downgraded Roivant Sciences Ltd’s stock and 0 analysts who upgraded over the last month.

Additionally, you'll want to evaluate Roivant Sciences Ltd’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on Roivant Sciences Ltd’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

Roivant Sciences Ltd’s current valuation based on AAII’s Value Grade is a D, which means it is considered to be Expensive.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about Roivant Sciences Ltd (ROIV) by visiting AAII Stock Evaluator.

Relative Price Strength of Roivant Sciences Ltd

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of April 02, 2024, Roivant Sciences Ltd has a weighted four-quarter relative price strength of 1.33%, which translates to a Momentum Score of 74 and is considered to be Strong.

Want to learn more about how Roivant Sciences Ltd is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

Roivant Sciences Ltd Stock Price: Bottom Line

As of April 3, 2024, Roivant Sciences Ltd’s stock price is $11.51, which is up 5.4% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like Roivant Sciences Ltd stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.